• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初次接种破伤风疫苗17至20年后的再次接种:抗体反应动力学

Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response.

作者信息

Simonsen O, Klaerke M, Jensen J E, Kjeldsen K, Hau C, Heron I

机构信息

Vaccine Department, State Serum Institute, Copenhagen, Denmark.

出版信息

J Trauma. 1987 Dec;27(12):1358-61. doi: 10.1097/00005373-198712000-00007.

DOI:10.1097/00005373-198712000-00007
PMID:3694727
Abstract

In 24 military recruits vaccinated against tetanus 17-20 years earlier antibody responses were studied 4, 11, and 24 days after revaccination. Antitoxin concentration in serum showed a sigmoid increase with titres at day 4 only just above protective level, corresponding to a risk of susceptibility to be expected even 4 days after revaccination (2.0%, 95% confidence limit). Only after 7 days the risk of unprotection was less than 1%. As the incubation period of tetanus can be as short as 24 hours, revaccination only may not be regarded sufficient if more than 17-20 years have elapsed since primary vaccination and conditions favoring rapid development of tetanus are present. The findings may explain some of the cases of tetanus which have occurred in spite of primary vaccination supplemented by emergency booster. The statement that prophylactic tetanus immunoglobulin is never indicated to persons completely vaccinated earlier should be considered for revision.

摘要

对24名17 - 20年前接种过破伤风疫苗的新兵,在再次接种疫苗后的第4天、第11天和第24天研究其抗体反应。血清中的抗毒素浓度呈S形增加,第4天的滴度仅略高于保护水平,这意味着即使在再次接种疫苗4天后仍有易感性风险(2.0%,95%置信区间)。仅在7天后,无保护的风险才低于1%。由于破伤风的潜伏期可短至24小时,如果自初次接种疫苗已过去17 - 20年以上且存在有利于破伤风快速发展的条件,仅再次接种疫苗可能不足以预防。这些发现或许可以解释一些尽管进行了初次接种并补充了应急加强针但仍发生破伤风的病例。对于之前已完全接种疫苗的人永远不需要预防性破伤风免疫球蛋白这一说法,应考虑进行修正。

相似文献

1
Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response.初次接种破伤风疫苗17至20年后的再次接种:抗体反应动力学
J Trauma. 1987 Dec;27(12):1358-61. doi: 10.1097/00005373-198712000-00007.
2
Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.日本旅行者破伤风类毒素抗体的血清流行率和加强免疫接种效果。
J Infect Chemother. 2014 Jan;20(1):35-7. doi: 10.1016/j.jiac.2013.11.003. Epub 2013 Dec 11.
3
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination.初次接种疫苗25 - 30年后的破伤风免疫及再次接种的效果
Lancet. 1984 Dec 1;2(8414):1240-2. doi: 10.1016/s0140-6736(84)92796-x.
4
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination.
Acta Pathol Microbiol Immunol Scand C. 1986 Apr;94(2):77-82. doi: 10.1111/j.1699-0463.1986.tb02093.x.
5
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus.
Vaccine. 1987 Jun;5(2):115-22. doi: 10.1016/0264-410x(87)90057-0.
6
Immunity against tetanus and response to revaccination in surgical patients more than 50 years of age.
Surg Gynecol Obstet. 1987 Apr;164(4):329-34.
7
Immune responses of Asian elephants (Elephas maximus) to commercial tetanus toxoid vaccine.亚洲象(印度象)对商用破伤风类毒素疫苗的免疫反应。
Vet Immunol Immunopathol. 2010 Feb 15;133(2-4):287-9. doi: 10.1016/j.vetimm.2009.08.005. Epub 2009 Aug 13.
8
A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis.一项关于重症肌无力患者破伤风疫苗再接种的体液免疫应答和安全性的前瞻性、安慰剂对照研究。
Vaccine. 2017 Nov 1;35(46):6290-6296. doi: 10.1016/j.vaccine.2017.09.078. Epub 2017 Oct 6.
9
[Increased level of tetanus antibody twenty one years after a booster dose of tetanus vaccine].
Acta Med Port. 2004 Mar-Apr;17(2):183-6. Epub 2004 Apr 30.
10
Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.根据儿童急性淋巴细胞白血病(ALL)协作组05/92方案治疗后的患儿白喉(D)和破伤风(T)抗体值。
Klin Padiatr. 2007 Nov-Dec;219(6):355-60. doi: 10.1055/s-2007-990290.